Watch all the conversations...

Since its inception in 2012, Microbiome Labs has valued education, collaboration, and research. To date, the company has attended, exhibited, and presented at more than 300 conferences; initiated and/or completed 14 clinical trials; and provided key solutions to thousands of practitioners, changing over 344,000 lives—and counting. Message us to see our research tables and studies we have completed… with many more to come!

Check out Dr. Pimentel's new book, The Microbiome Connection, which is available through all major booksellers. If it's out of stock, grab the Kindle version.

Dr. Mark Pimentel is the top research doctor in the fields of IBS (Irritable Bowel Syndrome), SIBO (Small Intestine Bacterial Overgrowth), IMO (Intestinal Methanogen Overgrowth), and other functional gut disorders. He is in the process of mapping the microbiome of the small intestine and other major research breakthroughs to support both physicians and patients in resolving these complex conditions. He spends his days working tirelessly in the Pimentel Laboratory at Cedars-Sinai Medical Center in Los Angeles. 

Steve Wright, co-founder of SCDLifestyle.com, is always full of practical, useful, action-oriented advice. He has been a pioneer in gut health education. His personal digestive health issues, IBS diagnosis, and his background as an engineer give him a unique perspective. He has literally helped millions heal their gut.

Watch all the conversations...

Dr. Ken Brown is a board certified gastroenterologist and has been in practice for over 20 years with a clinical focus on inflammatory bowel disease and irritable bowel syndrome and small intestinal bacterial overgrowth. With his approach of never being satisfied with the status quo & combined with the knowledge that there is always a better answer.

Dr. Brown has declared that his mission is to bridge the gap between medical & natural science. For over a decade he has been conducting clinical research for various pharmacologic companies. After treating and conducting research with thousands of patients, he easily recognized an unmet need for something natural that could help his IBS patients find real relief.

Dr. Jason Hawrelak presents a case study (15-years in the making) and his research data on which substrate is best for diagnosing SIBO. The results are very surprising! 

Dr. Jason Hawrelak is Head of Research at ProbioticAdvisor.com. His passion for gastrointestinal health, the GIT microbiota, and probiotics was ignited during the final year of his undergraduate training. Subsequently, Dr Hawrelak did his Honours (First Class) and PhD degrees in the areas of the gastrointestinal microbiota, irritable bowel syndrome, and the clinical applications of pre- and probiotics. He has written extensively in the medical literature  on these topics – including 16 textbook chapters – and his research has been cited over 800 times. Dr. Hawrelak has taught health professionals at both the undergraduate and postgraduate level for the past 18 years.

This is a Masterclass Dr. Robillard taught specifically for our community: Gut Dysbiosis & Digestive Health: How to Restore Your Gut Microbes to A Healthy Balance Naturally

And if you prefer to just listen or read, we've also included the transcript and audio file.

Satish S.C. Rao, MD, PhD, is an award-winning Professor of Medicine and Chief of the Division of Gastroenterology/Hepatology at the Digestive Health Center at Augusta University (Georgia). His research interests focus on the pathophysiology and treatment of inflammatory bowel disease, food intolerance (particularly fructose), constipation, fecal incontinence, and visceral pain, particularly esophageal chest pain. He has pioneered several new techniques of evaluating esophageal, gastric, colonic, and anorectal function, in particular the brain-gut axis, for which he has several patents, and he has pioneered technique of biofeedback therapy for dyssynergic defecation. He is currently investigating the neurobiologic mechanisms of biofeedback therapy and pioneering new treatments for fructose intolerance.